BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1985689)

  • 41. [Changes in erythrocyte fluidity, fragility and deformability and serum lipid peroxide content in early burn period].
    Gu T; Sun Y
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1994 Mar; 10(2):124-6. PubMed ID: 7922812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.
    Hebbel RP; Boogaerts MA; Eaton JW; Steinberg MH
    N Engl J Med; 1980 May; 302(18):992-5. PubMed ID: 7366623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.
    Hebbel RP; Eaton JW; Steinberg MH; White JG
    Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of erythrocytes in thromboembolism pathology].
    Wautier JL
    Ann Med Interne (Paris); 1986; 137(6):477-9. PubMed ID: 3813282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes.
    Mosseri M; Bartlett-Pandite AN; Wenc K; Isner JM; Weinstein R
    Am Heart J; 1993 Aug; 126(2):338-46. PubMed ID: 8338004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Red blood cell deformability and hemolytic anemias.
    Mohandas N; Phillips WM; Bessis M
    Semin Hematol; 1979 Apr; 16(2):95-114. PubMed ID: 384522
    [No Abstract]   [Full Text] [Related]  

  • 48. Stomatocytosis is absent in "stomatin"-deficient murine red blood cells.
    Zhu Y; Paszty C; Turetsky T; Tsai S; Kuypers FA; Lee G; Cooper P; Gallagher PG; Stevens ME; Rubin E; Mohandas N; Mentzer WC
    Blood; 1999 Apr; 93(7):2404-10. PubMed ID: 10090952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial adhesivity of sickle red blood cells.
    Hebbel RP
    J Lab Clin Med; 1992 Oct; 120(4):503-4. PubMed ID: 1402324
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of lactadherin in the phagocytosis of phosphatidylserine-expressing sickle red blood cells by macrophages.
    Dasgupta SK; Thiagarajan P
    Haematologica; 2005 Sep; 90(9):1267-8. PubMed ID: 16154850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and function of transmembrane glycoproteins--the red cell model.
    Wise GE
    Tissue Cell; 1984; 16(5):665-76. PubMed ID: 6515639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
    Morris CL; Gruppo RA; Shukla R; Rucknagel DL
    J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The structural organization of skeletal proteins influences lipid translocation across erythrocyte membrane.
    Mohandas N; Rossi M; Bernstein S; Ballas S; Ravindranath Y; Wyatt J; Mentzer W
    J Biol Chem; 1985 Nov; 260(26):14264-8. PubMed ID: 4055777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion.
    Setty BN; Kulkarni S; Stuart MJ
    Blood; 2002 Mar; 99(5):1564-71. PubMed ID: 11861269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 56. Sickle cell disease--pathophysiology, clinical and diagnostic implications.
    Dorn-Beineke A; Frietsch T
    Clin Chem Lab Med; 2002 Nov; 40(11):1075-84. PubMed ID: 12521222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
    Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
    J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.
    de Jong K; Emerson RK; Butler J; Bastacky J; Mohandas N; Kuypers FA
    Blood; 2001 Sep; 98(5):1577-84. PubMed ID: 11520810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormal rheology of oxygenated blood in sickle cell anemia.
    Chien S; Usami S; Bertles JF
    J Clin Invest; 1970 Apr; 49(4):623-34. PubMed ID: 5443167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.